CA1033727A - Preparation of w-pentanorprostaglandins - Google Patents

Preparation of w-pentanorprostaglandins

Info

Publication number
CA1033727A
CA1033727A CA185,366A CA185366A CA1033727A CA 1033727 A CA1033727 A CA 1033727A CA 185366 A CA185366 A CA 185366A CA 1033727 A CA1033727 A CA 1033727A
Authority
CA
Canada
Prior art keywords
pentanorprostaglandins
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA185,366A
Other languages
English (en)
French (fr)
Other versions
CA185366S (en
Inventor
Thomas K. Schaaf
Hans-Jurgen E. Hess
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Ltd Great Britain
Original Assignee
Pfizer Ltd Great Britain
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Ltd Great Britain filed Critical Pfizer Ltd Great Britain
Application granted granted Critical
Publication of CA1033727A publication Critical patent/CA1033727A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0025—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing keto groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/30—Compounds having groups
    • C07C43/315—Compounds having groups containing oxygen atoms singly bound to carbon atoms not being acetal carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C62/00—Compounds having carboxyl groups bound to carbon atoms of rings other than six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C62/30—Unsaturated compounds
    • C07C62/34—Unsaturated compounds containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4018—Esters of cycloaliphatic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/54—Quaternary phosphonium compounds
    • C07F9/5407—Acyclic saturated phosphonium compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
CA185,366A 1972-11-08 1973-11-08 Preparation of w-pentanorprostaglandins Expired CA1033727A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30475072A 1972-11-08 1972-11-08

Publications (1)

Publication Number Publication Date
CA1033727A true CA1033727A (en) 1978-06-27

Family

ID=23177829

Family Applications (1)

Application Number Title Priority Date Filing Date
CA185,366A Expired CA1033727A (en) 1972-11-08 1973-11-08 Preparation of w-pentanorprostaglandins

Country Status (20)

Country Link
JP (1) JPS5714347B2 (OSRAM)
AT (1) AT345999B (OSRAM)
BE (1) BE807046A (OSRAM)
CA (1) CA1033727A (OSRAM)
CH (1) CH593930A5 (OSRAM)
DE (1) DE2355731C3 (OSRAM)
DK (1) DK143499C (OSRAM)
ES (3) ES420386A1 (OSRAM)
FI (1) FI58912C (OSRAM)
FR (3) FR2205338B1 (OSRAM)
GB (1) GB1456838A (OSRAM)
IE (1) IE40043B1 (OSRAM)
IL (2) IL50310A (OSRAM)
IN (1) IN139265B (OSRAM)
NL (1) NL7315307A (OSRAM)
NO (2) NO143663C (OSRAM)
PH (2) PH13261A (OSRAM)
SE (4) SE412229B (OSRAM)
SU (2) SU667131A3 (OSRAM)
ZA (1) ZA738595B (OSRAM)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1431561A (en) * 1973-01-31 1976-04-07 Ici Ltd Cyclopentane derivatives
US3929862A (en) * 1974-01-08 1975-12-30 Upjohn Co Substituted tolylesters of PGF{HD 2{B {60
JPS5823393B2 (ja) * 1974-03-14 1983-05-14 オノヤクヒンコウギヨウ カブシキガイシヤ プロスタグランジンルイジカゴウブツ ノ セイゾウホウホウ
US4028396A (en) * 1975-07-02 1977-06-07 American Cyanamid Company 16,16-Spirocycloalkyl prostaglandin derivatives
US4074063A (en) * 1976-02-11 1978-02-14 Miles Laboratories, Inc. Bicycloalkyl derivatives of prostaglandins
NZ183136A (en) * 1976-02-11 1978-11-13 Miles Lab Monospiroalkyl derivatives of prostaclandis and pharmaceutical compositions
US4404372A (en) * 1977-06-13 1983-09-13 Pfizer Inc. 15-Substituted-ω-pentanorprostaglandin derivatives
DE2753995A1 (de) * 1977-12-03 1979-06-07 Bayer Ag Neue bicycloalkenyl-prostaglandine und verfahren zu ihrer herstellung
HUP0004436A3 (en) * 1997-09-09 2001-09-28 Procter & Gamble Aromatic c16-c20-substituted tetrahydro prostaglandins useful as fp agonists
BR9811774A (pt) * 1997-09-09 2000-08-29 Procter & Gamble Tetraidroprostaglandinas aromáticas substituìdas por c16-c20 úteis como agonistas fp
SK3382000A3 (en) * 1997-09-09 2000-10-09 Procter & Gamble A compound having structure of aromatic substituted prostaglandins and its use for the treatment of bone disorders
CA2364948C (en) * 1999-03-05 2011-04-26 Duke University C16 unsaturated fp-selective prostaglandins analogs
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
US20020037914A1 (en) 2000-03-31 2002-03-28 Delong Mitchell Anthony Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins
US20020172693A1 (en) 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
ATE432910T1 (de) * 2007-11-28 2009-06-15 Bauer Maschinen Gmbh Winde
US8722739B2 (en) 2008-10-29 2014-05-13 Novaer Holdings, Inc. Amino acid salts of prostaglandins
US8623918B2 (en) 2008-10-29 2014-01-07 Novaer Holdings, Inc. Amino acid salts of prostaglandins
US12565468B2 (en) * 2021-08-23 2026-03-03 Chirogate International Inc. Processes and intermediates for the preparations of Carboprost and Carboprost Tromethamine, and Carboprost Tromethamine prepared therefrom

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4864073A (OSRAM) * 1971-04-30 1973-09-05

Also Published As

Publication number Publication date
DE2355731C3 (de) 1981-01-15
SE7701523L (sv) 1977-02-10
NO143663B (no) 1980-12-15
DK143499C (da) 1982-01-11
AU6230273A (en) 1975-05-08
SU704456A3 (ru) 1979-12-15
FR2205338B1 (OSRAM) 1978-07-13
BE807046A (fr) 1974-05-08
IL43571A (en) 1977-08-31
IE40043B1 (en) 1979-02-28
NO743616L (no) 1974-05-09
NL7315307A (OSRAM) 1974-05-10
FI58912C (fi) 1981-05-11
DE2355731A1 (de) 1974-05-22
SE412229B (sv) 1980-02-25
FR2205338A1 (OSRAM) 1974-05-31
IL50310A (en) 1977-08-31
ATA941073A (de) 1978-02-15
ES444398A1 (es) 1977-12-01
ES456279A1 (es) 1978-11-01
IN139265B (OSRAM) 1976-05-29
NO144385C (no) 1981-08-19
FR2291200B1 (OSRAM) 1979-01-05
SU667131A3 (ru) 1979-06-05
FI58912B (fi) 1981-01-30
DE2355731B2 (de) 1980-04-30
SE7612261L (sv) 1976-11-03
NO144385B (no) 1981-05-11
CH593930A5 (OSRAM) 1977-12-30
JPS5714347B2 (OSRAM) 1982-03-24
AT345999B (de) 1978-10-10
FR2291200A1 (fr) 1976-06-11
SE7612262L (sv) 1976-11-03
ZA738595B (en) 1974-09-25
PH13261A (en) 1980-02-25
SE417957B (sv) 1981-04-27
GB1456838A (en) 1976-11-24
ES420386A1 (es) 1976-07-01
PH13320A (en) 1980-03-13
JPS49133357A (OSRAM) 1974-12-21
IE40043L (en) 1974-05-08
DK143499B (da) 1981-08-31
FR2286147A1 (fr) 1976-04-23
IL43571A0 (en) 1974-03-14
NO143663C (no) 1981-03-25
FR2286147B1 (OSRAM) 1978-09-22

Similar Documents

Publication Publication Date Title
CA1020554A (en) Preparation of thiocarbamylsulfenamides
CA989190A (en) Manufacture of fabrics
CA1014161A (fr) Procede de preparation de thiazolsulfenamides
CA1029734A (en) Manufacture of benzil-monoketals
CA1014977A (en) Preparation of 1-butene
CA984579A (en) Preparation of 238pu16o2
CA999002A (en) Preparation of nitrophenylpyridines
AU474093B2 (en) Chemosterilization of ixodides
AU472072B2 (en) Preparation of 3-fluoro-d-alanine
CA1028701A (en) Preparation of thiocarbamylsulfenamides
CA900491A (en) Preparation of tertiary-amino-substituted-alkylamines
CA889866A (en) Preparation of methallylsilanes
CA895293A (en) Preparation of 7-halolincomycins
CA916174A (en) Preparation of o-chlorophenols
CA892042A (en) Preparation of phenazine-di-n-oxides
CA901593A (en) Preparation of beta-halogenopropionitriles
CA893149A (en) Preparation of perfluoroolefines
CA915160A (en) Preparation of piperidyl-steroids
CA899360A (en) Preparation of oxindolecarboxamides
CA897709A (en) Preparation of peroxyboranes
CA895859A (en) Preparation of 21-fluoro-steroids
AU488391B2 (en) Preparation of 2-nitro-4-amino-phenylaniline
CA899911A (en) Preparation of perchlorofluoropropanes
CA915201A (en) Preparation of nitro-hexafluorocuminols
AU477850B2 (en) Preparation of thiocarbamylsulfenamides